934388-45-1

Basic information

• Product Name: 4-(1-AMINO-ETHYL)-BENZOIC ACID METHYL ESTER HYDROCHLORIDE
• Synonyms: 4-(1-AMINO-ETHYL)-BENZOIC ACID METHYL ESTER HYDROCHLORIDE;Methyl 4-(1-aMinoethyl)benzoate hydrochloride;Methyl 4-(1-aminoethyl)benzoate HCl
• CAS NO: 934388-45-1
• Molecular Formula: C₁₀H₁₃NO₂*ClH
• Molecular Weight: 215.68
• Mol File: 934388-45-1.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-(1-AMINO-ETHYL)-BENZOIC ACID METHYL ESTER HYDROCHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(1-AMINO-ETHYL)-BENZOIC ACID METHYL ESTER HYDROCHLORIDE(934388-45-1)
• EPA Substance Registry System: 4-(1-AMINO-ETHYL)-BENZOIC ACID METHYL ESTER HYDROCHLORIDE(934388-45-1)

Safety Data

• Hazardous Substances Data: 934388-45-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-(1-AMINO-ETHYL)-BENZOIC ACID METHYL ESTER HYDROCHLORIDE is used as a precursor in the synthesis of various drugs for its ability to improve solubility and facilitate pharmaceutical formulations.
Used in Organic Chemistry:
4-(1-AMINO-ETHYL)-BENZOIC ACID METHYL ESTER HYDROCHLORIDE is used as a valuable compound in the field of organic chemistry for its potential medicinal properties and its role in the development of new drugs.

Upstream product

• 3609-53-8 methyl 4-acetylbenzoate 
• 74733-31-6 methyl 4-(1-(hydroxyimino)ethyl)benzoate 

Downstream Products

• 1332890-06-8 4-(1-{[(2,4-dimethylphenyl)sulfonyl]amino}ethyl)-N-hydroxybenzamide 
• 1332891-64-1 4-[1-({[(4-cyanophenyl)amino]carbonyl}amino)ethyl]-N-hydroxybenzamide 
• 1332891-14-1 N-(1-{4-[(hydroxyamino)carbonyl]phenyl}ethyl)-3-isopropyl-1-methyl-1H-pyrazole-5-carboxamide 
• 1332892-85-9 N-(1-{4-[(hydroxyamino)carbonyl]phenyl}ethyl)-1-methyl-1H-pyrrole-2-carboxamide 
• 1207861-06-0 methyl 4-[1-({[2-(3-fluorobenzyl)-3-thienyl]carbonyl}amino)ethyl]benzoate 
• 934388-15-5 4-[1-(2,2,2-trifluoro-acetylamino)-ethyl]-benzoic acid methyl ester 

Relevant articles and documents

SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF

This invention provides compounds of formula (I): wherein ring A, X1, X2, X3, R2, R4b, R10, and G have values as described in the specification, useful as inhibitors of HDAC6. The invention also provides pharmaceutical compositions comprising the compounds of the invention, and methods of using the compositions in the treatment of proliferative, inflammatory, infectious, neurological or cardiovascular diseases or disorders.

THIOPHENECARBOXAMIDE DERIVATIVES AS EP4 RECEPTOR LIGANDS

The invention is directed to thiophenecarboxamide derivatives of formulae I and II as EP4 receptor ligands, antagonists or agonists, useful for the treatment of EP4 mediated diseases or conditions, such as acute and chronic pain, osteoarthritis, rheumatoi

KINASE INHIBITORS

The present invention relates to new AGC kinase inhibitors, in particular to compounds of Formula I, II, or III or a stereoisomer, tautomer, racemic, metabolite, pro- or predrug, salt, hydrate, or solvate thereof, I II III wherein X, R1, R2, R3, R31, n, and m have the meaning defined in the claims. In particular, the present invention relates more specifically to ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease.

Secondary amines, their preparation and use in pharmaceutical compositions

The compounds of the formula (II): STR1 and their pharmaceutically acceptable salts wherein R1 is a hydrogen, fluorine or chlorine atom or a hydroxyl, hydroxymethyl, methyl, methoxyl, amino, formamido, acetamido, methylsulphonylamido, nitro, benzyloxy, methylsulphonylmethyl, ureido, trifluoromethyl or p-methoxybenzylamino group; R2 is a hydrogen, fluorine or chlorine atom or a hydroxyl group; R3 is a hydrogen or chlorine atom or a hydroxyl group; R4 is a carboxylic acid group or a salt, ester or amide thereof; R5 is a hydrogen, chlorine or fluorine atom or a methyl, methoxyl or hydroxyl group or a carboxylic acid group or a salt, ester or amide thereof; R6 is a hydrogen atom or a methyl, or propyl group; X is an oxygen atom or a bond; and Y is an alkylene group of up to 6 carbon atoms or a bond have been found to possess anti-obesity and/or antihyperglycaemic activity.